APA (7th ed.) Citation

Nicholls, S. J., Nissen, S. E., Fleming, C., Urva, S., Suico, J., Berg, P. H., . . . Michael, L. F. (2023). Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial. JAMA : the journal of the American Medical Association, 330(11), 1042-1053. https://doi.org/10.1001/jama.2023.16503

Chicago Style (17th ed.) Citation

Nicholls, Stephen J., et al. "Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial." JAMA : The Journal of the American Medical Association 330, no. 11 (2023): 1042-1053. https://doi.org/10.1001/jama.2023.16503.

MLA (9th ed.) Citation

Nicholls, Stephen J., et al. "Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial." JAMA : The Journal of the American Medical Association, vol. 330, no. 11, 2023, pp. 1042-1053, https://doi.org/10.1001/jama.2023.16503.